APO Research
Talk to an analyst

APO RESEARCH · REPORT

9-valent HPV Vaccine (9vHPV)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global 9-valent HPV Vaccine (9vHPV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025176 pages

Choose your research edition.

Industry Research9-valent HPV Vaccine (9vHPV) Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal 9-valent HPV Vaccine (9vHPV) Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal 9-valent HPV Vaccine (9vHPV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 9-valent HPV Vaccine (9vHPV) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal 9-valent HPV Vaccine (9vHPV) Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global 9-valent HPV Vaccine (9vHPV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for 9-valent HPV Vaccine (9vHPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of 9-valent HPV Vaccine (9vHPV) include GSK, Merck and Beijing Wantai Biology Pharmaceutical Industry Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global 9-valent HPV Vaccine (9vHPV) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of 9-valent HPV Vaccine (9vHPV) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents 9-valent HPV Vaccine (9vHPV) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the 9-valent HPV Vaccine (9vHPV) market size, projected growth trends, production technologies, key applications, and end-use industries.

9-valent HPV Vaccine (9vHPV) Segment by Company

GSK

Merck

Beijing Wantai Biology Pharmaceutical Industry Limited

9-valent HPV Vaccine (9vHPV) Segment by Type

9—14

15—19

20—45

9-valent HPV Vaccine (9vHPV) Segment by Application

Men

Women

9-valent HPV Vaccine (9vHPV) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 9-valent HPV Vaccine (9vHPV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 9-valent HPV Vaccine (9vHPV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 9-valent HPV Vaccine (9vHPV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of 9-valent HPV Vaccine (9vHPV) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global 9-valent HPV Vaccine (9vHPV) industry.

Chapter 3: Detailed analysis of 9-valent HPV Vaccine (9vHPV) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, 9-valent HPV Vaccine (9vHPV)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 9—14 Table 3. Key Players of 15—19 Table 4. Key Players of 20—45 Table 4. Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Men Table 6. Key Players of Women Table 7. Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2021-2026) & (US$ Million) Table 9. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region (2021-2026) Table 10. Global 9-valent HPV Vaccine (9vHPV) Market Size by Region (2027-2032) & (US$ Million) Table 11. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region (2027-2032) Table 12. 9-valent HPV Vaccine (9vHPV) Industry Trends Table 13. 9-valent HPV Vaccine (9vHPV) Industry Drivers Table 14. 9-valent HPV Vaccine (9vHPV) Industry Opportunities and Challenges Table 15. 9-valent HPV Vaccine (9vHPV) Industry Restraints Table 16. Global 9-valent HPV Vaccine (9vHPV) Revenue by Company (US$ Million) & (2021-2026) Table 17. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Company (2021-2026) Table 18. Global 9-valent HPV Vaccine (9vHPV) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global 9-valent HPV Vaccine (9vHPV) Key Company Head Office and Area Served Table 20. Global 9-valent HPV Vaccine (9vHPV) Company, Product Type & Application Table 21. Global 9-valent HPV Vaccine (9vHPV) Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global 9-valent HPV Vaccine (9vHPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 26. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 27. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Type (2021-2026) Table 28. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Type (2027-2032) Table 29. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 31. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 32. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Application (2021-2026) Table 33. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Application (2027-2032) Table 34. GSK Company Information Table 35. GSK Business Overview Table 36. GSK 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. GSK 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 38. GSK Recent Development Table 39. Merck Company Information Table 40. Merck Business Overview Table 41. Merck 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Merck 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 43. Merck Recent Development Table 44. Beijing Wantai Biology Pharmaceutical Industry Limited Company Information Table 45. Beijing Wantai Biology Pharmaceutical Industry Limited Business Overview Table 46. Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Product Portfolio Table 48. Beijing Wantai Biology Pharmaceutical Industry Limited Recent Development Table 49. North America 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 50. North America 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 51. North America 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 52. North America 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 53. North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) Table 55. North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032) Table 56. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 57. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 58. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 59. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 60. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) Table 62. Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032) Table 63. China 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 64. China 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 65. China 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 66. China 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 67. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 68. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 69. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 70. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 71. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) Table 73. Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032) Table 74. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026) & (US$ Million) Table 75. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032) & (US$ Million) Table 76. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026) & (US$ Million) Table 77. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032) & (US$ Million) Table 78. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026) Table 80. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. 9-valent HPV Vaccine (9vHPV) Product Image Figure 2. Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global 9-valent HPV Vaccine (9vHPV) Market Share by Type: 2025 VS 2032 Figure 4. 9—14 Image Figure 5. 15—19 Image Figure 6. 20—45 Image Figure 7. Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global 9-valent HPV Vaccine (9vHPV) Market Share by Application: 2025 VS 2032 Figure 9. Men Image Figure 10. Women Image Figure 11. Global 9-valent HPV Vaccine (9vHPV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 13. Global 9-valent HPV Vaccine (9vHPV) Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global 9-valent HPV Vaccine (9vHPV) Market Share by Players in 2025 Figure 16. Global Top 5 and 10 9-valent HPV Vaccine (9vHPV) Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Type (2021-2032) Figure 20. Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global 9-valent HPV Vaccine (9vHPV) Revenue Market Share by Application (2021-2032) Figure 22. North America 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 23. North America 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032) Figure 24. North America 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032) Figure 25. North America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 26. United States 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 27. Canada 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 28. Mexico 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 29. Europe 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 30. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032) Figure 31. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032) Figure 32. Europe 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 33. Germany 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 34. France 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 35. U.K. 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 36. Italy 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 37. Russia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 39. China 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 40. China 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032) Figure 41. China 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032) Figure 42. Asia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 43. Asia 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032) Figure 44. Asia 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032) Figure 45. Asia 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 46. Japan 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 47. South Korea 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 50. India 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 51. Australia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032) Figure 56. Brazil 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 57. South Africa 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 59. Turkey 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 60. Argentina 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 61. UAE 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 62. Egypt 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 63. Chile 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • 9—14
  • 15—19
  • 20—45
Applications
  • Men
  • Women
Companies covered
  • GSK
  • Merck
  • Beijing Wantai Biology Pharmaceutical Industry Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 9—14
  5. 1.2.3 15—19
  6. 1.2.4 20—45
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global 9-valent HPV Vaccine (9vHPV) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Men
  10. 1.3.3 Women
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global 9-valent HPV Vaccine (9vHPV) Growth Trends by Region
  13. 1.5.1 Global 9-valent HPV Vaccine (9vHPV) Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 9-valent HPV Vaccine (9vHPV) Market Size by Region (2021-2026)
  15. 1.5.3 9-valent HPV Vaccine (9vHPV) Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global 9-valent HPV Vaccine (9vHPV) Market Dynamics
  1. 2.1 9-valent HPV Vaccine (9vHPV) Industry Trends
  2. 2.2 9-valent HPV Vaccine (9vHPV) Industry Drivers
  3. 2.3 9-valent HPV Vaccine (9vHPV) Industry Opportunities and Challenges
  4. 2.4 9-valent HPV Vaccine (9vHPV) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global 9-valent HPV Vaccine (9vHPV) Revenue by Company (2021-2026)
  2. 3.2 Global 9-valent HPV Vaccine (9vHPV) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global 9-valent HPV Vaccine (9vHPV) Key Company Head office and Area Served
  4. 3.4 Global 9-valent HPV Vaccine (9vHPV) Company, Product Type & Application
  5. 3.5 Global 9-valent HPV Vaccine (9vHPV) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global 9-valent HPV Vaccine (9vHPV) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 9-valent HPV Vaccine (9vHPV) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 9-valent HPV Vaccine (9vHPV) Tier 1, Tier 2, and Tier 3
4 9-valent HPV Vaccine (9vHPV) Market by Type
  1. 4.1 Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2032)
  3. 4.3 Global 9-valent HPV Vaccine (9vHPV) Market Size Share by Type (2021-2032)
5 9-valent HPV Vaccine (9vHPV) Market by Application
  1. 5.1 Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2032)
  3. 5.3 Global 9-valent HPV Vaccine (9vHPV) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GSK 9-valent HPV Vaccine (9vHPV) Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck 9-valent HPV Vaccine (9vHPV) Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Beijing Wantai Biology Pharmaceutical Industry Limited
  14. 6.3.1 Beijing Wantai Biology Pharmaceutical Industry Limited Company Information
  15. 6.3.2 Beijing Wantai Biology Pharmaceutical Industry Limited Business Overview
  16. 6.3.3 Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Beijing Wantai Biology Pharmaceutical Industry Limited 9-valent HPV Vaccine (9vHPV) Product Portfolio
  18. 6.3.5 Beijing Wantai Biology Pharmaceutical Industry Limited Recent Developments
7 North America
  1. 7.1 North America 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  2. 7.2 North America 9-valent HPV Vaccine (9vHPV) Market Size by Type
  3. 7.2.1 North America 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026)
  4. 7.2.2 North America 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032)
  5. 7.2.3 North America 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032)
  6. 7.3 North America 9-valent HPV Vaccine (9vHPV) Market Size by Application
  7. 7.3.1 North America 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026)
  8. 7.3.2 North America 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032)
  9. 7.3.3 North America 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032)
  10. 7.4 North America 9-valent HPV Vaccine (9vHPV) Market Size by Country
  11. 7.4.1 North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  13. 7.4.3 North America 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032)
  14. 7.4.4 North America 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  2. 8.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Type
  3. 8.2.1 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026)
  4. 8.2.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032)
  5. 8.2.3 Europe 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032)
  6. 8.3 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Application
  7. 8.3.1 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026)
  8. 8.3.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032)
  9. 8.3.3 Europe 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032)
  10. 8.4 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country
  11. 8.4.1 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  13. 8.4.3 Europe 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032)
  14. 8.4.4 Europe 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  2. 9.2 China 9-valent HPV Vaccine (9vHPV) Market Size by Type
  3. 9.2.1 China 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026)
  4. 9.2.2 China 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032)
  5. 9.2.3 China 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032)
  6. 9.3 China 9-valent HPV Vaccine (9vHPV) Market Size by Application
  7. 9.3.1 China 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026)
  8. 9.3.2 China 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032)
  9. 9.3.3 China 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  2. 10.2 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Type
  3. 10.2.1 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026)
  4. 10.2.2 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032)
  5. 10.2.3 Asia 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032)
  6. 10.3 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Application
  7. 10.3.1 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026)
  8. 10.3.2 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032)
  9. 10.3.3 Asia 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032)
  10. 10.4 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country
  11. 10.4.1 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  13. 10.4.3 Asia 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032)
  14. 10.4.4 Asia 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa 9-valent HPV Vaccine (9vHPV) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst